Clinical trial

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in…

NCT00351130 · Novartis, Industry · Completed

Key facts

NCT number NCT00351130
Title Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
Official title An 8 Week Extension to a Randomized, Double-blind, Parallel Group, Active-controlled, Multi-center, 14 Week Study to Evaluate the Effectiveness of a Valsartan Versus and Amlodipine Treatment Strategy in Achieving Blood Pressure Control in Patients With Stage 1 or Stage 2 Hypertension or Uncontrolled…
Lead sponsor Novartis, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hypertension
Intervention type Drug
Interventions valsartan, amlodipine
Enrollment 79
Start date Jun 1, 2006
Primary completion Mar 1, 2007
Completion Mar 1, 2007
First posted Jul 12, 2006
Last update posted Feb 24, 2017
Countries Germany, Switzerland

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies